Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-01-10 @ 4:52 PM
Study NCT ID:
NCT03834961
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2019-01-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Sponsor:
Children's Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-07-25
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-22
First Submit QC Date:
None
Study First Post Date:
2019-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-16
Results First Submit QC Date:
None
Results First Post Date:
2025-12-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED